Natriumchlorid Deltamedica (Sodium Chloride)

Sodium chloride increases the concentration of sodium in the extracellular fluid, raising plasma osmolality. This osmotic shift draws water into the vascular compartment, expanding blood volume and correcting low serum sodium levels, thereby supporting normal cellular and organ function.

The dose of Natriumchlorid Deltamedica is determined by the prescribing clinician based on the patient’s electrolyte status, fluid needs, weight, and clinical condition. The prescriber selects the appropriate concentration, volume, and infusion rate for each individual case.

Sodium chloride is a naturally occurring electrolyte, but the safety of Natriumchlorid Deltamedica during pregnancy or lactation should be evaluated by a healthcare professional. The prescriber will consider the maternal and fetal benefits versus any potential risks before use.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Natriumchlorid Deltamedica is a generic sodium chloride injection that provides the same electrolyte and volume replacement benefits as other isotonic saline solutions. Differences may lie in manufacturing standards, packaging, and regulatory compliance, with GNH India offering GDP‑certified supply for international markets.

The product should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and allow the vial to reach room temperature if required for administration.

Natriumchlorid Deltamedica is administered by intramuscular, intravenous, or subcutaneous injection. The route, infusion rate, and total volume are determined by the prescriber according to the patient’s clinical condition and therapeutic goals.

Serious risks include severe hypernatremia, pulmonary edema from fluid overload, cardiac arrhythmias, and rare anaphylactic reactions. Monitoring serum sodium, fluid balance, and patient vital signs during and after infusion helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride solutions, uncontrolled hypertension, severe heart failure, or renal failure requiring strict fluid restriction should avoid or use the product only under close medical supervision.